Artiva Biotherapeutics, Inc. (ARTV)
Nasdaq: ARTV · CIK 0001817241 · United States
Every official Artiva Biotherapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ARTV filings
Artiva Biotherapeutics, Inc. documents
- Artiva Biotherapeutics, Inc. 10-K 2026ARTV 10-K 2026: annual report for fiscal 2026
- Artiva Biotherapeutics, Inc. 10-K 2025ARTV 10-K 2025: annual report for fiscal 2025
- Artiva Biotherapeutics, Inc. 10-K 2024ARTV 10-K 2024: annual report for fiscal 2024
- Artiva Biotherapeutics, Inc. 10-K 2023ARTV 10-K 2023: annual report for fiscal 2023
- Artiva Biotherapeutics, Inc. 10-K 2022ARTV 10-K 2022: annual report for fiscal 2022
- Artiva Biotherapeutics, Inc. 10-Q 2026ARTV 10-Q 2026: quarterly report for fiscal 2026
- Artiva Biotherapeutics, Inc. 10-Q 2025ARTV 10-Q 2025: quarterly report for fiscal 2025
- Artiva Biotherapeutics, Inc. 10-Q 2024ARTV 10-Q 2024: quarterly report for fiscal 2024
- Artiva Biotherapeutics, Inc. 10-Q 2023ARTV 10-Q 2023: quarterly report for fiscal 2023
- Artiva Biotherapeutics, Inc. 10-Q 2022ARTV 10-Q 2022: quarterly report for fiscal 2022
- Artiva Biotherapeutics, Inc. 8-K 2026ARTV 8-K 2026: current report for fiscal 2026
- Artiva Biotherapeutics, Inc. 8-K 2025ARTV 8-K 2025: current report for fiscal 2025
- Artiva Biotherapeutics, Inc. 8-K 2024ARTV 8-K 2024: current report for fiscal 2024
- Artiva Biotherapeutics, Inc. 8-K 2023ARTV 8-K 2023: current report for fiscal 2023
- Artiva Biotherapeutics, Inc. 8-K 2022ARTV 8-K 2022: current report for fiscal 2022
- Artiva Biotherapeutics, Inc. DEF 14A 2026ARTV DEF 14A 2026: proxy statement for fiscal 2026
- Artiva Biotherapeutics, Inc. DEF 14A 2025ARTV DEF 14A 2025: proxy statement for fiscal 2025
- Artiva Biotherapeutics, Inc. DEF 14A 2024ARTV DEF 14A 2024: proxy statement for fiscal 2024
- Artiva Biotherapeutics, Inc. DEF 14A 2023ARTV DEF 14A 2023: proxy statement for fiscal 2023
- Artiva Biotherapeutics, Inc. DEF 14A 2022ARTV DEF 14A 2022: proxy statement for fiscal 2022
- Artiva Biotherapeutics, Inc. Form 4 2026ARTV Form 4 2026: insider trading filing for fiscal 2026
- Artiva Biotherapeutics, Inc. Form 4 2025ARTV Form 4 2025: insider trading filing for fiscal 2025
- Artiva Biotherapeutics, Inc. Form 4 2024ARTV Form 4 2024: insider trading filing for fiscal 2024
- Artiva Biotherapeutics, Inc. Form 4 2023ARTV Form 4 2023: insider trading filing for fiscal 2023
- Artiva Biotherapeutics, Inc. Form 4 2022ARTV Form 4 2022: insider trading filing for fiscal 2022
- Artiva Biotherapeutics, Inc. S-1 2026ARTV S-1 2026: registration statement for fiscal 2026
- Artiva Biotherapeutics, Inc. S-1 2025ARTV S-1 2025: registration statement for fiscal 2025
- Artiva Biotherapeutics, Inc. S-1 2024ARTV S-1 2024: registration statement for fiscal 2024
- Artiva Biotherapeutics, Inc. S-1 2023ARTV S-1 2023: registration statement for fiscal 2023
- Artiva Biotherapeutics, Inc. S-1 2022ARTV S-1 2022: registration statement for fiscal 2022
- Artiva Biotherapeutics, Inc. 13F 2026ARTV 13F 2026: institutional holdings for fiscal 2026
- Artiva Biotherapeutics, Inc. 13F 2025ARTV 13F 2025: institutional holdings for fiscal 2025
- Artiva Biotherapeutics, Inc. 13F 2024ARTV 13F 2024: institutional holdings for fiscal 2024
- Artiva Biotherapeutics, Inc. 13F 2023ARTV 13F 2023: institutional holdings for fiscal 2023
- Artiva Biotherapeutics, Inc. 13F 2022ARTV 13F 2022: institutional holdings for fiscal 2022
More companies